64 results
Page 2 of 4
8-K
EX-99.1
drwq cy14dmkf0554xe
13 Jan 20
Regulation FD Disclosure
8:45am
8-K
EX-99.1
s2lw 13sgrl
15 Apr 19
Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of PulmazoleTM
5:00pm
UPLOAD
nq5 2lbiu
8 Apr 19
Letter from SEC
12:00am
424B4
rfslj3v
5 Apr 19
Prospectus supplement with pricing info
4:31pm
8-K
EX-99.1
0ax 1tctyqy
1 Apr 19
Entry into a Material Definitive Agreement
4:16pm
UPLOAD
b8d8l14qzy6h33zj
25 Mar 19
Letter from SEC
12:00am
UPLOAD
c8cyu2lnm7ts77
14 Mar 19
Letter from SEC
12:00am
8-K
EX-99.1
uj14v21db
19 Feb 19
Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline
9:05am
424B5
dsfjsxnoiyqs 2g
11 Feb 19
Prospectus supplement for primary offering
5:13pm
424B5
9bged rg8vrux7d3nwe
31 Jan 19
Prospectus supplement for primary offering
5:11pm
424B5
qfhi70pbhnity47 zl3
30 Jan 19
Prospectus supplement for primary offering
4:21pm
424B5
hd03nlbs
30 Jan 19
Prospectus supplement for primary offering
12:00am